modern research center for new technology and innovations in …€¦ · zabrze silesian park of...
TRANSCRIPT
http://www.bing.com
KARDIO-MED SILESIA SILESIAN CENTRE FOR HEART DISEASES
Scientific environment:
• Medical University of Silesia,
• Silesian University of Technology,
• Polish Academy of Sciences
Zabrze
Silesian Park of Medical Technology Kardio-Med Silesia
Modern Research Center for New Technology and
Innovations in Medicine and Biotechnology
2
Silesian Park of Medical Technology Kardio-Med Silesia
Clinical Trials Center
Research Center for New Technology and Innovations
in Medicine and Biotechnology
Modern lab facility
GLP standard
Training Center
Facility for experiments on small and big animals model
3Kardio-Med Silesia Ltd.
Kardio-Med Silesia Medical Technology Park
Academy of Health in
Innovation
MedTrends
European Forum of Modern
Health Care
Educationactivities
4
Kardio - Med Silesia organizes the annual cyclic meeting dedicated to novel technologies in health
care (www.medtrends.pl)
”MedTrends – European Modern Health Care Forum” is a conference whose attendants are leading experts
representing fields of cardiology, cardiac surgery, diabetes, neurology, and genomics who aim to exchange
knowledge and experience concerning research and development of modern solutions in medicine between
various representatives of science, medicine, new technology and telemedicine solutions as well as Polish,
British and European businesses. The conference focuses on personalised medicine, e-Health tools, 3D
print and e-education in medicine.
Additionally, innovatory medical start-ups have a chance to present their ideas to a range of leading
figures from the world of medicine, investment societies and business experts during "TOP-TRENDS"
competition.
The fifth edition of the MedTrends 2019 conference will be held in 2019.
More information on the conference website: www.medtrends.pl
MedTrends Conference
Kardio-Med Silesia Ltd.
Induced pluripotent stem cells (iPSC)
Amabile G & Meissner A (2009) Induced pluripotent stem cells: current
progress and potential for regenerative medicineTrends Mol. Med. 15:59
Adult Somatic
CellsShinya Yamanaka 2006
Nobel Prize - 2012
Sendai Vectors: Oct4,
Sox2, Klf, c-Myc)
Kardio-Med Silesia Ltd.
PLANNED ACTIVITIESA comprehensive cell platform to study the efficacy and toxicity of potential
medicinal substances based on iPSC and lab-on-chip technology
Regenerative medicine
Disease mechanisms
Drug research
https://www.eurostemcell.org/ips-cells-and-reprogramming-turn-any-cell-body-stem-cell
Human IPSCs applications
Advantages: models closer to physiological repeatability, ease of use real time measurements possibility automation possibility for long-term cultures low cost compared to in vivo tests
Opportunity:• early phase of technology development (few offers of functional products)
Organ-on-chip technology is a cell culturecarried out in a microfluidic device thatstimulates the physiological conditions of aspecific organ (or organ system), regarded asadvanced in vitro research model.
Aim:
The use of stem cells (iPSC reprogrammed) in combination with organ-on-chip to create auniversal and simple platform for drug testing and study of the complex mechanisms underlyingdiseases.
Range of activities
iPSC organ-on-chip
Disease model
Contact:Kamila Luft – Head of Project [email protected] Pietryga – PhD – Main [email protected]
Phone: +48 32 70 50 305
Silesian Park of Medical Technology Kardio-Med SilesiaMarii Curie-Skłodowskiej 10 c41-800 Zabrze, POLAND
www.en.kmptm.pl